Error loading player: No playable sources found
AM23-ST-18-O
AM23-ST-18-O: Potential Role of Intravenous Hemostatic Agents/Adjuncts in Pediatric Trauma: A Review of the Evidence for (or Against) Their Use (Enduring)
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)
$30
Standard Price
Members save $5
This session will focus on the role of anti-fibrinolytics and other hemostatic agents/adjuncts (such as prothrombin concentrates, rFVIIa, fibrinogen concentrates/cryoprecipitate) in controlling bleeding and lowering transfusion needs in pediatric trauma situations. Key animal experimental studies and pediatric/adult clinical studies that support its use in attenuating bleeding in pediatric patients will be presented. In addition, assays that can guide the use of hemostatic agents/adjuncts will be described.
Learning Objectives
- Understand the difference in hemostasis between children and adults.
- Describe the evidence for (or against) the use of tranexaminc acid in pediatric trauma and non-trauma bleeding situations.
- Describe the evidence for (or against) the use of other hemostatic agents/adjuncts such as prothrombin concentrates (PCC) and other hemostatic agents (eg. rFVIIa, fibrinogen concentrates/cryoprecipitate) in pediatric trauma.
- Describe assays that can guide use of these agents/adjuncts in bleeding pediatric patients.
Moderator
Speakers
Professor, Department of Pathology, University of New Mexico HSC
Phillip Spinella, MD
Professor of Surgery and Critical Care Medicine, University of Pittsburgh
Tracks
Related Products
AM23-SN-29-O: The Approach to Bleeding in Patients Receiving Targeted Factor XI Therapy (Enduring)
The ideal goal of anticoagulant therapy is to attenuate thrombosis without compromising hemostasis. Although newer oral anticoagulants such as apixaban, rivaroxaban, and edoxaban are associated with less intracranial hemorrhage than vitamin K antagonists, bleeding remains their major side effect…
AM24-ST-29-O: Case Studies: Cyber Threats in Healthcare (Enduring)
Join us for an essential panel discussion on cybersecurity in healthcare, where real-world insights and expert analysis come together to enhance your organization's defenses. This session features three distinguished speakers from hospitals and blood centers that have faced cybersecurity attacks…
AM24-MN-17-O: Making Learning Stick – Effective Training for Blood and Biotherapies Professionals (Enduring)
The future of the blood and biotherapies fields depends on our ability to prepare a new generation of leaders and skilled professionals to continue advancing the field…
